Anti-TNF-α Agents in Inflammatory Bowel Disease and Course of COVID-19

Inflamm Bowel Dis. 2020 Jun 18;26(7):e73. doi: 10.1093/ibd/izaa114.
No abstract available

Publication types

  • Comment

MeSH terms

  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections
  • Humans
  • Inflammatory Bowel Diseases*
  • Italy
  • Pandemics
  • Pneumonia, Viral
  • SARS-CoV-2
  • Tumor Necrosis Factor-alpha*

Substances

  • Tumor Necrosis Factor-alpha